glp-1 agonist medications Agonists: A Comprehensive Overview GLP-1 Receptor Agonists and Research
Description
HBI, HarveyBradshaw Index
doi: 10.1055/s-2004-826175 141 MeierJJGallwitzBSalmenSGoetzeOHolstJJSchmidtWEet al
The bottom line: Retatrutide is promising to be a great tool for help with weight loss, but its not the only path forward for many people today
A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)
